Living Kidney Donor clinical trials at UCSF
1 research study open to eligible people

• Treg Therapy in Subclinical Inflammation in Kidney Transplantation

  open to eligible people ages 18 years and up

  The purpose of this study is: - To see if polyTregs and/or "donor reactive" darTregs can reduce inflammation in a transplanted kidney. - To find out what effects, good or bad, polyTregs or darTregs will have in the kidney recipient. - To find out what effects, good or bad, taking everolimus after polyTregs or darTregs will have in the kidney recipient.

  San Francisco, California and other locations

Last updated: March 29, 2019